Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndrome-Reference-Cited by-同舟云学术

Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndrome

Published:2009-03-12 Issue:7 Volume:23 Page:1288-1296
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Zou J X,Rollison D E,Boulware D,Chen D-T,Sloand E M,Pfannes L V,Goronzy J J,Bai F,Painter J S,Wei S,Cosgrove D,List A F,Epling-Burnette P K

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu200914.pdf

Reference62 articles.

1. Lim ZY, Cook G, Johnson PR, Zuckerman M, Marks D, Wiltshire H et al. Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin. Leukemia 2007; 21: 1436–1441.

2. Sun M, Zhang J, Liu S, Liu Y, Zheng D . Sp1 is involved in 8-chloro-adenosine-upregulated death receptor 5 expression in human hepatoma cells. Oncol Rep 2008; 19: 177–185.

3. Young NS . Immunosuppressive treatment of acquired aplastic anemia and immune-mediated bone marrow failure syndromes. Int J Hematol 2002; 75: 129–140.

4. Molldrem JJ, Jiang YZ, Stetler-Stevenson M, Mavroudis D, Hensel N, Barrett AJ . Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles. Br J Haematol 1998; 102: 1314–1322.

5. Kochenderfer JN, Kobayashi S, Wieder ED, Su C, Molldrem JJ . Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppression. Blood 2002; 100: 3639–3645.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of immune cells in mediating the relationship between gut microbiota and myelodysplastic syndrome: a bidirectional two-sample, two-step Mendelian randomization study;Discover Oncology;2024-05-31

2. T-cell dysfunctions in myelodysplastic syndromes;Blood;2024-04-04

3. Myelodysplastic syndromes: 2023 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2023-06-08

4. Analysis of Immune-Cell Distribution of Bone Marrow in Patients with Myelodysplastic Syndrome;Hematology Reports;2023-01-12

5. In the Pipeline: Emerging Therapy for MDS and MDS/MPN;Pathogenesis and Treatment of Leukemia;2023